Search

Majid M Vakilynejad

from Andover, MA
Age ~61
Get Report
Also known as:
Majid M Vakily, Najid Vakilynejad, Tina Vakilynejad, Vakilynejad Majid, Majid D
Related to:
Erich Goodenough, 40Christopher Scholle, 40Carroll Scholle, 83
Connected to:
Fariba Vakilzadian, 64Charles K Vakirtzis, 71Dorothea J Vakis, 69Sridevi A Vakkalanka, 46Asher V Vaknin, 52Michal Vaknin, 54Moshe Vaknin, 61Nissim N Vaknin, 63Ortal Vaknin, 42Ran Y Vaknin, 51

Majid Vakilynejad Phones & Addresses

  • Andover, MA
  • Pleasant Prairie, WI
  • 18030 Hampshire Dr, Gurnee, IL 60031 (847) 855-0185
  • Lake Bluff, IL
  • Montclair, NJ
  • Lane, IL

Publications

Us Patents

Multiple Ppi Dosage Form

View page
US Patent:
20130245071, Sep 19, 2013
Filed:
Apr 30, 2013
Appl. No.:
13/874219
Inventors:
Majid Vakilynejad - Pleasant Prairie WI, US
International Classification:
A61K 31/4439
US Classification:
514338
Abstract:
Herein provided are dosage forms (variously referred to as “formulations”) comprising a PPI that is released from the dosage form as a first and a second dose. Each dose of PPI is present in an amount sufficient to raise the plasma levels of the PPI to at least 100 ng/ml.

Novel Modified Release Dosage Forms Of Xanthine Oxidoreductase Inhibitor Or Xanthine Oxidase Inhibitors

View page
US Patent:
20110311620, Dec 22, 2011
Filed:
Jun 15, 2011
Appl. No.:
13/160572
Inventors:
Rajneesh Taneja - Libertyville IL, US
Vijay Gupte - Vernon Hills IL, US
Majid Vakilynejad - Gurnee IL, US
Assignee:
Takeda Pharmaceuticals North America, Inc. - Deerfield IL
International Classification:
A61K 9/58
A61K 31/426
A61K 9/14
A61K 9/26
A61P 3/10
A61P 1/00
A61P 9/10
A61P 9/12
A61P 13/12
A61P 3/00
C07D 277/24
A61P 19/06
US Classification:
424462, 548201, 514365, 424497, 424469
Abstract:
The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.

Novel Modified Release Dosage Forms Of Xanthine Oxidoreductase Inhibitor Or Xanthine Oxidase Inhibitors

View page
US Patent:
20160317505, Nov 3, 2016
Filed:
Jan 29, 2016
Appl. No.:
15/010212
Inventors:
- Deerfield IL, US
Vijay Gupte - Vernon Hills IL, US
Majid Vakilynejad - Pleasant Prairie WI, US
Assignee:
Takeda Pharmaceuticals U.S.A., Inc. - Deerfield IL
International Classification:
A61K 31/426
A61K 9/00
A61K 9/16
A61K 9/28
Abstract:
The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.

Multiple Ppi Dosage Form

View page
US Patent:
20160058788, Mar 3, 2016
Filed:
Nov 11, 2015
Appl. No.:
14/938670
Inventors:
- DEERFIELD IL, US
Majid Vakilynejad - Pleasant Prairie WI, US
International Classification:
A61K 33/00
A61K 31/4439
Abstract:
Herein provided are dosage forms (variously referred to as “formulations”) comprising a PPI that is released from the dosage form as a first and a second dose. Each dose of PPI is present in an amount sufficient to raise the plasma levels of the PPI to at least 100 ng/ml.
Control profile
Majid M Vakilynejad from Andover, MA, age ~61 Get Report